Available Until 12/16/2025

Ambulatory Care Pharmacy Clinical Sessions (Cert # L249220)

ACPE Numbers: Various – see listing below
Content Release Date: December 18, 2024
Expiration Date: December 16, 2025
Activity Type: Application-based
CE Credits: 6.0 hours contact hours (ACPE and BPS)
Activity Fee: $155 (ASHP member); $260 (non-member)

Activity Overview

This Clinical Sessions package is intended for board-certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in ambulatory care. 

The Ambulatory Care Pharmacy Clinical Sessions Recertification Package consists of 4 activities (see table below) and provides up to 6.0 contact hours of continuing pharmacy education and/or recertification credit. 

These activities are part of the ASHP and ACCP professional development program for BCACP recertification approved by BPS. For pharmacists who maintain more than one certification, three of the activities are approved for multiple specialties (see table below).

These activities were presented as part of the 2024 ACCP Annual Meeting and 2024 ASHP Midyear Clinical Meeting. Learners who claimed ACPE credit for these activities as part of that meeting should not claim ACPE credit again.

ACPE Provider with Commendation logoThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

  

    

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • Updates of atrial fibrillation guidelines
  • Smoking cessation in older adults
  • Newer antidiabetic medications
  • Treatments for osteoporosis and bone disorders in special populations

Board-certified pharmacists are eligible to receive up to 6.0 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.   

ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.


ACCP and ASHP are approved by BPS as a provider for the recertification of BCACP.

Learning Activity

Passing Score

Credit Information

The Beat Goes On: Updates in Atrial Fibrillation Guidelines

72%

1.5 Contact Hours

BPS: BCACP
ACPE: 0217-9999-24-070-H01-P 

Clearing the Clouds: Navigating Smoking Cessation in Older Adults

80%

1.5 Contact Hours

BPS: BCACP, BCGP
ACPE: 0217-9999-24-065-H01-P

A New Day in Diabetes Control for the Older Adult? Using Newer Medications Across the Continuum of Care

70%

1.5 Contact Hours

BPS: BCACP, BCGP
ACPE: 0204-9999-24-324-H01-P 

Bone Health Updates: “Breaking” Down Literature in Special Populations for Treatments of Osteoporosis and Other Bone Disorders

68%

1.5 Contact Hours

BPS: BCACP, BCGP
ACPE: 0204-9999-24-348-H01-P 

The Beat Goes On: Updates in Atrial Fibrillation Guidelines
ACPE: 0217-9999-24-070-H01-P

  • Compare the top 10 take-home messages from the 2023 Atrial Fibrillation (AF) Guidelines to recommendations from the 2014 and 2019 guidelines.
  • Evaluate 2023 AF guideline use in ambulatory care, focusing on the updated staging system's impact on patient management, emphasizing preventive measures and lifestyle modifications.
  • Develop an evidence-based treatment plan using patient-specific factors based on the 2023 AF guidelines, considering patient adherence, lifestyle modifications, and monitoring challenges.

This activity is approved for Board-Certified Ambulatory Care Pharmacist (BCACP) recertification credit. 

Clearing the Clouds: Navigating Smoking Cessation in Older Adults
ACPE: 0217-9999-24-065-H01-P

  • Evaluate first-line pharmacotherapy options for treating older adults with tobacco dependence.
  • Compare and contrast monotherapy versus combination pharmacotherapy for the treatment of older adults with tobacco dependence.
  • Design an individualized smoking cessation treatment plan for an older adult patient.
  • Evaluate obstacles encountered by older adults associated with tobacco cessation and recommend solutions.
  • Summarize areas in which a clinical pharmacist can impact the care of older adults with tobacco dependence.

This activity is approved for Board-Certified Ambulatory Care Pharmacist (BCACP) and Board-Certified Geriatric Pharmacist (BCGP) recertification credit. 

A New Day in Diabetes Control for the Older Adult? Using Newer Medications Across the Continuum of Care
ACPE: 0204-9999-24-324-H01-P

  • Evaluate the evidence base of newer diabetic agents in the older adult.
  • Design a regimen for an older adult with diabetes considering goals and patient-related variables.
  • Formulate a plan for addressing medication-related problems associated with the newer agents for diabetes in the older adult.
  • Develop a transition plan for an older adult patient with diabetes from one care venue to another.

This activity is approved for Board-Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit. 

Bone Health Updates: “Breaking” Down Literature in Special Populations for Treatments of Osteoporosis and Other Bone Disorders

ACPE: 0204-9999-24-348-H01-P

  • Identify risk factors and treatment of osteoporosis, vitamin D deficiency, and other bone disorders.
  • Interpret recent changes in safety, duration, and efficacy of selected therapy, including the removal of the boxed warning to PTH analogs.
  • Assess treatment of osteoporosis and bone diseases in selected patient populations, including men, steroid-induced osteoporosis, pediatrics, and geriatrics.
  • Develop a treatment plan for an individual with osteoporosis given patient-specific information.

This activity is approved for Board-Certified Ambulatory Care Pharmacist (BCACP) and Board-Certified Geriatric Pharmacist (BCGP) recertification credit.

Faculty bios

Trista Bailey, PharmD, BCPS, BCGP, FASCP
Associate Professor
Texas Tech University Health Sciences Center - School of Pharmacy 

Jill Borchert, PharmD, BCPS, BCACP, FCCP
Professor and Vice Chair
Midwestern University College of Pharmacy 

Dana Carroll, PharmD, BCPS, BCGP, CDCES
Clinical Professor
Auburn University Harrison College of Pharmacy 

Ellen Jones, PharmD, BCACP
Assistant Professor of Pharmacy Practice
Harding University College of Pharmacy
Ambulatory Care Pharmacy Specialist
MetroHealth System 

Kazuhiko Kido, PharmD, FCCP, BCCP, BCPS
Clinical Associate Professor of Clinical Pharmacy
West Virginia University

Laura A. Schalliol, PharmD, BCACP, BCGP            
Associate Professor of Pharmacy Practice
South College School of Pharmacy

Kelsee Tignor, PharmD
PGY-1 Resident and Clinical Instructor
South College School of Pharmacy 

Mallory Turner, PharmD, BCPS, BCCP
Associate Professor of Pharmacy Practice
Harding University College of Pharmacy

Sue Dombrowski, MS, RPh
Karen L. Kier, PhD, BCPS, BCACP, FASHP, FCCP
Albert Joseph Nosser, Jr, PharmD, BCACP, BCMTMS
Lindsay Saum, PharmD, BCPS, BCGP
Paul Joseph Solinsky, PharmD, BCACP, AE-C, TTS 

Michelle Abalos, PharmD
Kristi Hofer, PharmD
Amy Holmes, PharmD, BCPPS
Anna Jackson, PharmD, BCPS

Maria Shin, PharmD, BCGP, BCPS
Dana Carroll, PharmD, BCPS, BCGP, CDCES
Michelle Hilaire, PharmD, FCCP, CDE, BCPS, BCACP

Carmela Avena-Woods, BSPharm, PharmD, BCGP
Laura Biancardi, PharmD, BCACP
Tyler Boland, PharmD, BCACP
Dawnna Burchett, PharmD, BCACP
Julie Caler, PharmD, BCGP
Maria Coyle, PharmD, BCPS, BCACP, CLS
Kate Cozart, MEd, PharmD, BCPS, BCGP, BCACP
Christin Davis, PharmD, BCGP, BCACP
Lorena DiGuiseppe, PharmD, BCACP
Erin Drees, PharmD
Ariel Ferdock, PharmD, BCPS, BCACP
Jenna Ferguson, PharmD, BCACP
Jenna Giacomin, PharmD, BCACP
Joanna Gustas, PharmD, BCACP
Paige Harrison, PharmD, BCACP
Laurie Hayes, PharmD, BCACP
Allyson Helms, PharmD, BCPS, BCACP, MS HSPA
Kajal Jain, BCACP
Brittany Johnson, PharmD, BCACP
Daniel Julien, PharmD, BCGP
Samantha Kaeberlein, PharmD, BCGP
Karen Kier, PhD, BCPS, BCACP
Zachary Klick, PharmD, BCPS, BCACP, BCCP
Prutha Lavani, PharmD, BCPS, BCCP, BCACP
Nicole Lee, PharmD, BCGP
Melissa Lipari, PharmD, BCACP
Kristine Lopez, PharmD, BCACP, BCGP
Bindu Mathews, PharmD, BCGP
Blair Maxwell, PharmD BCACP
Stephanie McAfee, PharmD, BCACP
Shingayi Molai, PharmD
Cassandra Mozes, PharmD, BCACP
Katelyn Neverman, PharmD, BCACP
Mursal Noor, PharmD, BCACP
Ina Norsworthy, PharmD, BCPS, BCACP
Joseph Nosser, PharmD, BCACP, BCMTMS
Rosalyn Otting, PharmD, BCGP
Casey Owen, PharmD, BCACP, CACP
Rakeshkumar Patel, PharmD, BCACP
Anna Pham, PharmD, BCACP
Lauren Pheasant, PharmD, BCACP
Bianca Romero, PharmD, BCPS, BCGP
Norbert Rosario, PharmD, BCPS, BCACP
Caroline Wagner Scheid, PharmD, BCGP
Catherine Schoenbaechler, PharmD, BCGP
Elise Shepard, PharmD, BCGP
Jennifer Stahl, PharmD, BCPS
Claire Stall, PharmD, BCACP
Anushka Tandon, PharmD, BCPS, BCACP
Lisa Tang, PharmD, BCACP
Mary Thoennes, RPh, CDCES, BCACP
Jennifer Tunoa, PharmD, BCACP, BCGP
Lisa Vick, PharmD, BCACP
Jonathan Weil, PharmD, BCACP, CSP
Sherry Whitley, PharmD, BCACP

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

ACCP and ASHP collaborate on ambulatory care pharmacy activities.